Sientra Receives Regulatory Approval to Market Breast Implants in Saudi Arabia

September 20, 2022

https://www.globenewswire.com/news-release/2022/09/20/2519153/33599/en/Sientra-Receives-Regulatory-Approval-to-Market-Breast-Implants-in-Saudi-Arabia.html

SANTA BARBARA, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced today that it has received approval from the Saudi Food & Drug Authority to market the Company’s line of smooth surface, High-Strength Cohesive (HSC and HSC+) silicone gel breast implants in the Kingdom of Saudi Arabia.

Read more at globenewswire.com

Related news for (SIEN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.